Literature DB >> 23587449

Seroepidemiology of Toxoplasma gondii infection in the Israeli population.

M Perry Markovich1, T Shohat, I Riklis, R Avni, D Yujelevski-Rozenblit, R Bassal, D Cohen, E Rorman.   

Abstract

Toxoplasmosis seroprevalence varies considerably between countries. We studied the seroprevalence of Toxoplasma gondii IgG antibodies in a national sample of the Israeli population; 2794 sera were tested. The highest age-adjusted seroprevalence rate was in Arabs (non-Bedouins) (60.4%), significantly higher compared to the rate in Jews (19.9%) and Bedouins (27.5%) (P < 0.01). There were no significant gender differences. Seropositivity increased with age in all population groups. For Jews, seropositivity was associated with place of birth and socioeconomic status. A finding of low seroprevalence rate in Bedouins despite their poor living conditions and close contact with livestock is surprising, and might be attributed to the dry and hot climate conditions in their area of residence. In women of reproductive age the seroprevalence was 15.1% in Jews, 25.4% in Bedouins and 72.3% in Arabs (non-Bedouins). Thus, the majority of pregnant women are susceptible to primary infection with T. gondii, and the risk for congenital toxoplasmosis remains high.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23587449      PMCID: PMC9152547          DOI: 10.1017/S0950268813000903

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  25 in total

1.  Evaluation of Toxoplasma gondii immunoglobulin G (IgG) and IgM assays incorporating the newVidia analyzer system.

Authors:  Adriana Calderaro; Giovanna Piccolo; Simona Peruzzi; Chiara Gorrini; Carlo Chezzi; Giuseppe Dettori
Journal:  Clin Vaccine Immunol       Date:  2008-05-14

2.  Prevalence of antibodies to Toxoplasma gondii in the Tel-Mond area.

Authors:  Z Nishri; S E Zalewski; L Glücks; R Avni; J Lederer; A Mates
Journal:  Isr J Med Sci       Date:  1993-01

3.  Seroprevalence of antibodies against Toxoplasma gondii among two rural populations in northern Israel.

Authors:  R Raz; Z Nishri; A Mates; G Sartani; N Hadad; N Reichman; D Miron; E Flatau
Journal:  Isr J Med Sci       Date:  1993-10

4.  Seroepidemiology of Toxoplasma gondii infection in women from the North of Portugal in their childbearing years.

Authors:  A P Lopes; J P Dubey; O Moutinho; M J Gargaté; A Vilares; M Rodrigues; L Cardoso
Journal:  Epidemiol Infect       Date:  2011-08-31       Impact factor: 2.451

5.  Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007.

Authors:  A Hofhuis; W van Pelt; Y T H P van Duynhoven; C D M Nijhuis; L Mollema; F R M van der Klis; A H Havelaar; L M Kortbeek
Journal:  Epidemiol Infect       Date:  2010-05-24       Impact factor: 2.451

6.  Seroprevalence of Toxoplasma gondii antibodies in a healthy population from Slovakia.

Authors:  Carmen Studenicová; Gabriela Bencaiová; Renata Holková
Journal:  Eur J Intern Med       Date:  2006-11       Impact factor: 4.487

Review 7.  Toxoplasma gondii: transmission, diagnosis and prevention.

Authors:  D Hill; J P Dubey
Journal:  Clin Microbiol Infect       Date:  2002-10       Impact factor: 8.067

8.  Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study.

Authors:  Sayed Nasser Mostafavi; Behrooz Ataei; Zari Nokhodian; Majid Yaran; Anahita Babak
Journal:  J Res Med Sci       Date:  2011-04       Impact factor: 1.852

9.  A 4-year evaluation of toxoplasmosis seroprevalence in the general population and in women of reproductive age in central Italy.

Authors:  M Mosti; B Pinto; A Giromella; S Fabiani; R Cristofani; M Panichi; F Bruschi
Journal:  Epidemiol Infect       Date:  2012-12-11       Impact factor: 4.434

10.  Laboratory diagnosis of Toxoplasma gondii infection.

Authors:  A Calderaro; S Peruzzi; G Piccolo; C Gorrini; S Montecchini; S Rossi; C Chezzi; G Dettori
Journal:  Int J Med Sci       Date:  2009-03-19       Impact factor: 3.738

View more
  14 in total

Review 1.  Health and morbidity among Bedouin women in southern Israel: a descriptive literature review of the past two decades.

Authors:  Yulia Treister-Goltzman; Roni Peleg
Journal:  J Community Health       Date:  2014-08

2.  Chorio-retinal toxoplasmosis: treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center.

Authors:  Vicktoria Vishnevskia-Dai; Asaf Achiron; Ortal Buhbut; Ofri Vorobichik Berar; Anne Ampaire Musika; Sivan M Elyashiv; Idan Hecht
Journal:  Int Ophthalmol       Date:  2019-12-02       Impact factor: 2.031

3.  Seroepidemiology and risk factors of Toxoplasma gondii infection in undergraduate university female students in Jordan.

Authors:  M M Obaidat; N A Al-Sheyab; A E Bani Salman; S Q Lafi
Journal:  Epidemiol Infect       Date:  2014-12-29       Impact factor: 4.434

4.  Seroprevalence and associated risk factors of Toxoplasma gondii infection in psychiatric patients: a case-control study in eastern China.

Authors:  W Cong; W Dong; L Bai; X-Y Wang; X-T Ni; A-D Qian; X-Q Zhu
Journal:  Epidemiol Infect       Date:  2015-02-17       Impact factor: 4.434

5.  Predictors of Toxoplasma gondii infection in Czech and Slovak populations: the possible role of cat-related injuries and risky sexual behavior in the parasite transmission.

Authors:  J Flegr
Journal:  Epidemiol Infect       Date:  2017-02-10       Impact factor: 4.434

6.  Toxoplasma gondii infection in interstate truck drivers: a case-control seroprevalence study.

Authors:  Cosme Alvarado-Esquivel; Sandy Janet Pacheco-Vega; Jesús Hernández-Tinoco; Misael Salcedo-Jáquez; Luis Francisco Sánchez-Anguiano; Luis Omar Berumen-Segovia; Elizabeth Rábago-Sánchez; Oliver Liesenfeld
Journal:  Parasit Vectors       Date:  2015-02-05       Impact factor: 3.876

7.  Seroprevalence of Toxoplasma gondii infection and associated risk factors in Huicholes in Mexico.

Authors:  Cosme Alvarado-Esquivel; Sandy Janet Pacheco-Vega; Jesús Hernández-Tinoco; Luis Francisco Sánchez-Anguiano; Luis Omar Berumen-Segovia; Francisco Javier Imard Rodríguez-Acevedo; Isabel Beristain-García; Elizabeth Rábago-Sánchez; Oliver Liesenfeld; Federico Campillo-Ruiz; Oscar Alberto Güereca-García
Journal:  Parasit Vectors       Date:  2014-07-01       Impact factor: 3.876

8.  Seroprevalence and correlates of Toxoplasma gondii infection in Yoremes (Mayos) in Mexico: a cross-sectional study.

Authors:  Cosme Alvarado-Esquivel; Antonio Rascón-Careaga; Jesús Hernández-Tinoco; María Alba Guadalupe Corella-Madueño; Luis Francisco Sánchez-Anguiano; María Lourdes Aldana-Madrid; Gerardo Javier Almada-Balderrama; Alan Daniel Nuñez-Aguirre; Oliver Liesenfeld
Journal:  BMJ Open       Date:  2016-05-12       Impact factor: 2.692

9.  Seroprevalence and associated risk factors of Toxoplasma gondii infection in the Korean, Manchu, Mongol and Han ethnic groups in eastern and northeastern China.

Authors:  X-X Zhang; Q Zhao; C-W Shi; W-T Yang; Y-L Jiang; Z-T Wei; C-F Wang; G-L Yang
Journal:  Epidemiol Infect       Date:  2016-02-02       Impact factor: 4.434

10.  Seroepidemiology of Toxoplasma gondii infection in Bai and Han ethnic groups in southwestern China.

Authors:  H-L Li; L Dong; Q Li; L Zhang; J Chen; F-C Zou; X-Q Zhu
Journal:  Epidemiol Infect       Date:  2014-06-16       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.